• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非瓣膜性心房颤动患者左心耳血栓的评估与管理。

Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation.

机构信息

McGill University Health Centre, Montreal, Quebec, Canada.

McGill University Health Centre, Montreal, Quebec, Canada; Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.

出版信息

Can J Cardiol. 2018 Mar;34(3):252-261. doi: 10.1016/j.cjca.2017.12.008. Epub 2017 Dec 15.

DOI:10.1016/j.cjca.2017.12.008
PMID:29395705
Abstract

BACKGROUND

Intracardiac thrombi arising in the left atrial appendage (LAA) are the principal cause of stroke in nonvalvular atrial fibrillation (AF). Predicting the presence of LAA thrombi is of vital importance in stratifying patients that would need further LAA imaging prior to cardioversion or AF ablation.

METHODS

We comprehensively searched PubMed from its inception to November 2017 for randomized controlled trials, cohort and case control studies, as well as for case series on LAA thrombi risk factors, imaging, prevention, and anticoagulation management in atrial fibrillation.

RESULTS

A systematic review of the literature identified 106 articles that investigated the presence of LAA thrombi in AF patients. We classified the articles according to topic and reported on: (1) risk factors; (2) diagnostic imaging modalities; (3) prevention strategies before cardioversion; (4) prevention strategies before AF ablation; and (5) management of detected LAA thrombi.

CONCLUSIONS

Integration of clinical, biomarker, and imaging risk factors can improve overall prediction for the presence of LAA thrombi, translating into improved patient selection for imaging. The gold standard for the diagnosis of LAA thrombi remains transesophageal echocardiography, although intracardiac ultrasound, cardiac computed tomography, and cardiovascular magnetic imaging are promising alternative modalities. When LAA thrombi are discovered, the treatment regimen remains variable, although direct oral anticoagulants might have efficacy similar to vitamin K antagonists. Future trials will help further elucidate direct oral anticoagulant use for the treatment of LAA thrombi.

摘要

背景

左心耳(LAA)内形成的心腔内血栓是导致非瓣膜性心房颤动(AF)患者发生中风的主要原因。预测 LAA 血栓的存在对于在电复律或 AF 消融之前对需要进一步进行 LAA 成像的患者进行分层非常重要。

方法

我们全面检索了从创建到 2017 年 11 月的 PubMed 数据库,以获取有关 LAA 血栓危险因素、成像、预防和 AF 抗凝管理的随机对照试验、队列和病例对照研究以及病例系列研究。

结果

对文献的系统回顾确定了 106 篇研究 AF 患者 LAA 血栓存在的文章。我们根据主题对文章进行了分类,并报告了:(1)危险因素;(2)诊断成像方式;(3)电复律前的预防策略;(4)AF 消融前的预防策略;和(5)检测到的 LAA 血栓的管理。

结论

整合临床、生物标志物和影像学危险因素可以提高 LAA 血栓存在的整体预测,从而改善对成像的患者选择。LAA 血栓的诊断标准仍然是经食管超声心动图,尽管腔内超声、心脏计算机断层扫描和心血管磁共振成像等都是有前途的替代方式。当发现 LAA 血栓时,治疗方案仍然存在差异,尽管直接口服抗凝剂可能与维生素 K 拮抗剂具有相似的疗效。未来的试验将有助于进一步阐明直接口服抗凝剂在 LAA 血栓治疗中的应用。

相似文献

1
Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动患者左心耳血栓的评估与管理。
Can J Cardiol. 2018 Mar;34(3):252-261. doi: 10.1016/j.cjca.2017.12.008. Epub 2017 Dec 15.
2
Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.左心耳封堵预防心房颤动患者卒中:一项随机对照试验的系统评价和网状Meta分析
J Cardiovasc Surg (Torino). 2018 Feb;59(1):128-139. doi: 10.23736/S0021-9509.17.09824-X. Epub 2017 Feb 17.
3
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).一项探索每日一次口服利伐沙班(X-TRA)对非瓣膜性心房颤动或心房扑动患者左心房/左心耳血栓结局影响的研究的原理与设计,以及一项提供基线数据的回顾性观察性注册研究(CLOT-AF)。
Am Heart J. 2015 Apr;169(4):464-71.e2. doi: 10.1016/j.ahj.2014.12.020. Epub 2015 Jan 6.
4
Systematic review of the management of atrial fibrillation in patients with heart failure.心力衰竭患者心房颤动管理的系统评价
Eur Heart J. 2000 Apr;21(8):614-32. doi: 10.1053/euhj.1999.1767.
5
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.口服抗凝剂与抗血小板治疗对预防非瓣膜性心房颤动且无卒中或短暂性脑缺血发作史患者卒中的疗效比较
Cochrane Database Syst Rev. 2007 Jul 18(3):CD006186. doi: 10.1002/14651858.CD006186.pub2.
6
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
7
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.用于预防非瓣膜性心房颤动且无既往卒中或短暂性脑缺血发作史患者卒中的口服抗凝药。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001927. doi: 10.1002/14651858.CD001927.pub2.
8
Comparison of prevalence and management of left atrial appendage thrombi under old and new anticoagulants prior to left atrial catheter ablation.左心房导管消融术前新旧抗凝剂治疗下左心耳血栓的患病率及管理比较。
Am Heart J. 2017 Nov;193:8-15. doi: 10.1016/j.ahj.2017.07.016. Epub 2017 Aug 2.
9
Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy - Warfarin vs. Direct Oral Anticoagulants.日本非瓣膜性心房颤动患者抗凝治疗期间左心耳血栓形成——华法林与直接口服抗凝剂的比较
Circ J. 2017 Apr 25;81(5):645-651. doi: 10.1253/circj.CJ-16-1089. Epub 2017 Feb 7.
10
Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation.接受口服抗凝治疗的心房颤动患者的左心耳血栓。
Cardiol J. 2024;31(3):461-471. doi: 10.5603/CJ.a2022.0054. Epub 2022 Jun 15.

引用本文的文献

1
Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients.直接口服抗凝剂(DOACs)与华法林用于房颤患者左心房血栓的比较。
Int J Cardiol Heart Vasc. 2025 Jul 8;59:101745. doi: 10.1016/j.ijcha.2025.101745. eCollection 2025 Aug.
2
Anticoagulation Failure in Stroke: Causes, Risk Factors, and Treatment.中风中的抗凝失败:原因、危险因素及治疗
J Stroke. 2025 May;27(2):195-206. doi: 10.5853/jos.2025.00206. Epub 2025 May 31.
3
Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy.
尽管接受了最佳的非维生素K拮抗剂口服抗凝药(NOAC)治疗,但仍存在左心耳血栓的房颤患者治疗策略的比较分析。
Clin Res Cardiol. 2025 May 6. doi: 10.1007/s00392-025-02665-w.
4
Crosslink between atrial fibrillation and cancer: a therapeutic conundrum.心房颤动与癌症之间的联系:一个治疗难题。
Cardiooncology. 2024 Aug 7;10(1):48. doi: 10.1186/s40959-024-00243-z.
5
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者血栓及淤滞物的形态与位置
BMC Cardiovasc Disord. 2024 Jul 31;24(1):398. doi: 10.1186/s12872-024-04073-w.
6
Influence of Meteorological Parameters on the Prevalence of TEE Detected Left Atrial Appendage Thrombi.气象参数对经食管超声心动图检测到的左心耳血栓患病率的影响。
Diseases. 2024 Jul 12;12(7):151. doi: 10.3390/diseases12070151.
7
Clinical case of Cor triatriatum sinister, a dilemma of anticoagulation: A case report and literature review.左三房心临床病例:抗凝治疗的困境——病例报告及文献综述
Clin Case Rep. 2024 Jun 25;12(7):e8908. doi: 10.1002/ccr3.8908. eCollection 2024 Jul.
8
Characteristics of non-valvular atrial fibrillation with left atrial appendage thrombus who are undergoing appropriate oral anticoagulation therapy.正在接受适当口服抗凝治疗的非瓣膜性心房颤动合并左心耳血栓患者的特征
Int J Cardiovasc Imaging. 2022 May;38(5):941-951. doi: 10.1007/s10554-021-02403-z. Epub 2022 Mar 30.
9
Management of cerebral amyloid angiopathy and atrial fibrillation: We are still far from precision medicine.脑淀粉样血管病与心房颤动的管理:我们距离精准医学仍有很大差距。
World J Cardiol. 2024 May 26;16(5):231-239. doi: 10.4330/wjc.v16.i5.231.
10
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study.左心耳血流速度对心房颤动伴左心耳血栓患者血栓溶解和临床结局的影响:来自 LAT 研究的观察。
Europace. 2024 May 2;26(5). doi: 10.1093/europace/euae120.